| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$213,655 |
D/D |
(15,869) |
145,541 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$23,265 |
D/D |
(1,728) |
99,689 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$18,715 |
D/D |
(1,390) |
108,310 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$17,826 |
D/D |
(1,324) |
204,826 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,737 |
161,410 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$15,181 |
D/D |
(1,045) |
79,986 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2013-02-19 |
4 |
S |
$14.53 |
$115,176 |
D/D |
(7,928) |
2,331,348 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$6,087 |
D/D |
(419) |
53,953 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$11,143 |
D/D |
(767) |
101,417 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$8,034 |
D/D |
(553) |
206,150 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$28,605 |
D/D |
(1,969) |
137,294 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$10,039 |
D/D |
(691) |
182,889 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$6,087 |
D/D |
(419) |
109,700 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$37,220 |
D/D |
(2,562) |
129,673 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2013-02-19 |
4 |
S |
$14.53 |
$11,143 |
D/D |
(767) |
58,274 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
37,720 |
139,263 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
54,372 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
110,119 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
117,120 |
2,339,276 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
183,580 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
81,031 |
|
- |
|
| Rodriguez Rama Francisco |
Senior V.P., Tech. Operations |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
8,420 |
31,349 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
102,184 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
59,041 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,470 |
206,703 |
|
- |
|
380 Records found
|
|
Page 3 of 16 |
|
|
